求人・転職情報

■Position Summary
You will lead epidemiology initiatives in Japan to inform development and lifecycle decisions. You will partner across clinical, safety, regulatory and commercial teams. You will shape study design, manage external partnerships, and translate real-world evidence into clear recommendations. We value curiosity, collaboration, and a practical approach that balances scientific rigour with timely decision-making. Join us to grow your career while helping GSK unite science, technology and talent to get ahead of disease together.

■Responsibilities
This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following:- Lead design, delivery and interpretation of epidemiology studies and real-world evidence projects in Japan.- Provide clear epidemiologic input to cross-functional teams including clinical development, safety, regulatory and market access.- Manage external partnerships and vendors to access data, deliver studies and ensure quality and timelines.- Produce study documents and outputs: protocols, analysis plans, final reports, regulatory input and scientific communications.- Represent GSK in scientific and regulatory discussions in Japan and with external experts.- Mentor colleagues and contribute to knowledge sharing and process improvements across the Epidemiology team.

■職務内容
Description:
The PS Epidemiologist (PSEPI) serves as a study lead for Post Authorization Regulatory Commitment Studies (PARCS) including post-marketing database study and use-result survey, accelerating the generation of valuable real-world evidence. Leveraging extensive clinical research expertise, including secondary data analysis, as well as various data assets and access rights held by AZKK, the PSEPI is responsible for the methodological reliability and scientific robustness at all stages of responsible research, from study planning and execution to study completion and publication. As an expert in epidemiological research, the PSEPI leads the education and utilization of real-world data within the Japan Patient Safety organization and contributes to organizational development.

Accountabilities/Responsibilities:
Strategic Evidence Planning
PSEPI contributes to the development of local Risk Management Plans (RMPs) preparing by Japan Patient Safety (PS). They start planning formulate Pharmacovigilance Plan (PVP) strategies and PARCS from the preparation stage of the new drug application (NDA) and lead discussions and consensus-building with internal stakeholders and regulatory authorities regarding PVP strategies for NDAs.

Study Execution
PSEPI creates study design concepts (SDC) and clinical study protocols (CSP) based on PVP strategies as the scientific lead for PARCS. They conduct feasibility assessments for PARCS and lead the technical review and approval of SDC/CSPs within the global governance related to evidence generation. In study execution and publicizing study results, the PSEPI leads regulatory processes, including epidemiological consultations, and engages with internal and external stakeholders. They oversee the execution of the analysis plan and the preparation of interim and final reports with study team members, ensuring quality by reviewing deliverables. They also support the planning and execution of external presentations and publication.

Leading team as an epidemiologist
In team working, the PSEPI serves as the leader of cross-functional study teams, leveraging members' expertise to ensure the successful execution of study activities. They provide coaching to study team members to support and accelerate their performance and facilitate smooth collaboration with cross-functional company-wide teams as a representative of Japan Patient Safety. As a skills leader, the PSEPI contributes to enhancing the real-world evidence (RWE) generation capabilities of PS Epidemiology & Evidence Generation members. They monitor changes in the external environment related to epidemiological research methodologies, available information sources, research-related technological trends, regulatory trends, and guidance on evidence generation in therapeutic areas, and lead the continuous improvement of deliverable quality by integrating these changes into company processes.

■ポジションの概要および目的
・国内の全ての安全性監視（PV）活動をリードする責任を負います。
　適切な国内PVシステムの展開、維持、継続的改善を確実に行います。
・国内のPVおよび市販後安全管理（PMS）プロセスが常に法令遵守、最新かつ監査対応可能な状態であることを保証し、グローバル患者安全部門（GPS）との主要な連絡窓口を務めます。
・国内における医療関連活動の主要な連絡先として、社内関係者との適切な調整と連携を図ります。
・日本の関連法規に基づき、国内PV/PMS体制の構築、実施、維持を担当し、国内のPV/PMS窓口を務めます。
・GPSおよびメディカルアフェアーズと連携し、PV/PMSの文書、システム、手順が継続的に法令遵守かつ準備万端の状態で維持されるようにします。
・観察研究および臨床試験活動に関する国内の主要な連絡先として、適切な監督と関連基準・ガイドラインの遵守を確保します。

・製造販売後のNPC製品の安全性、有効性並びに品質に関する適切な評価のための、調査/試験等を立案、実施、管理する。再審査品目に関しては、最終責任者（製造販売後調査等管理責任者）として再審査申請～承認までを責任を持って完遂する。市販後調査部の組織体制を維持、改善し、円滑かつ適切な業務を推進する。

【製造販売後調査等業務関連】
・使用性成績調査等の立案・実施・管理監督
・NPCが製造販売する製品の製造販売後調査等業務を適正かつ円滑に行う
・「医薬品の製造販売後の調査及び試験の実施の基準に関する省令（GPSP）」に基づき各手順書、組織体制、管理体制を管理、監督する
・製造販売後調査等（使用成績調査、他）の立案と実施・変更
・製造販売後調査等委託業務の適正性・指示の履行状況の確認・改善指示
・製造販売後調査等に関する製造販売業者への報告・意見の具申

【再審査関連業務】
・再審査申請、再審査適合性調査において、適正かつ円滑に準備、対応するため、本部長および安全管理責任者と連携を構築、維持する
・再審査申請・再評価時の資料の作成・提出
・GPSP-SOPの作成、改訂と管理
・製造販売後調査等の管理部門及び実施部門の教育訓練の立案と実施
・製造販売後調査等に関する当局対応

【市販後調査部の人事・業務管理】
・市販後調査部内の業務改善及び部員の採用・指名・管理・評価
・市販後調査部内の予算・経費管理
・市販後調査部内のスタッフのキャリア開発、人材育成